Author

K. K. Kolluri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

S. M. Janes· 3 shared A. Ben Aissa· 1 shared A. Edwards· 1 shared A. Huebner· 1 shared A. J. Rowan· 1 shared A. Pennycuick· 1 shared A. U. Akarca· 1 shared B. D. Weil· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. M. Janes

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genomic evolution of non-small cell lung cancer patient-derived xenograft models

R. E. Hynds, A. Huebner, D. R. Pearce, A. U. Akarca, D. A. Moore, S. Ward, K. H. C. Gowers, T. Karasaki, M. S. Hill, M. Al Bakir, G. A. Wilson, O. Pich, M. Sivakumar, A. Ben Aissa, E. Gronroos, , C. Swanton

This study examines how well PDX models capture intratumour heterogeneity in NSCLC, finding that most models originate from a single subclone but regional models can capture diversity.

bioRxiv · Jan 6, 2023Cancer Biology

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma

Y. Ishii, K. K. Kolluri, A. Pennycuick, E. Nigro, D. Alrifai, E. Borg, M. Falzon, K. Shah, N. Kumar, S. M. Janes

This study shows BAP1 and YY1 suppress TRAIL receptor expression in MPM, making them potential targets to enhance TRAIL therapy.

bioRxiv · Aug 31, 2020Cancer Biology

89Zr-oxine labelling and PET imaging shows lung delivery of a cell/gene cancer therapy

P. S. Patrick, K. K. Kolluri, M. Zaw Thin, A. Edwards, E. K. Sage, T. Sanderson, B. D. Weil, J. C. Dickson, M. F. Lythgoe, M. Lowdell, S. M. Janes, T. L. Kalber

The paper demonstrates that 89Zr-oxine PET imaging can track MSCTRAIL cell therapy biodistribution in a lung cancer mouse model, showing lung delivery and viability.

bioRxiv · Aug 22, 2019 · PreprintCell Biology